High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient

CorrectSequence Therapeutics Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen China Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/high-precision-base-editing-clinical-treatment-for-sickle-cell-disease--correctsequence-therapeutics-cs-101-achieves-promising-results-in-first-patient-302537833.html